天坛生物(600161.SH)：第三季度净利润1.86亿元，同比下降42.84%

Core Viewpoint - TianTan Biological (600161.SH) reported a revenue of 1.355 billion yuan for Q3 2025, reflecting a year-on-year growth of 9.96%, while the net profit attributable to shareholders decreased by 42.84% to 186 million yuan, with basic earnings per share at 0.09 yuan [1] Financial Performance - Revenue for Q3 2025 reached 1.355 billion yuan, marking a 9.96% increase compared to the previous year [1] - Net profit attributable to shareholders was 186 million yuan, showing a significant decline of 42.84% year-on-year [1] - Basic earnings per share stood at 0.09 yuan [1]